Attenuation of Experimental Atherosclerosis by Interleukin-19
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Objective—: Interleukin-19 (IL-19) is a putative Th2, anti-inflammatory interleukin. Its expression and potential role in atherogenesis are unknown. IL-19 is not detected in normal artery and is expressed to a greater degree in plaque from symptomatic versus asymptomatic patients, suggesting a compensatory counter-regulatory function. We tested whether IL-19 could reduce atherosclerosis in susceptible mice and identified plausible mechanisms. Approach and Results—: LDLR −/− mice fed an atherogenic diet and injected with either 1.0 or 10.0 ng/g per day recombinant mouse IL-19 had significantly less plaque area in the aortic arch compared with controls ( P <0.0001). Weight gain, cholesterol, and triglyceride levels were not significantly different. Gene expression in splenocytes from IL-19–treated mice demonstrated immune cell Th2 polarization, with decreased expression of T-bet, interferon-γ, interleukin-1β, and interleukin-12β and increased expression of GATA3 and FoxP3 mRNA. A greater percentage of lymphocytes were Th2 polarized in IL-19–treated mice. Cellular characterization of plaque by immunohistochemistry demonstrated that IL-19–treated mice have significantly less macrophage infiltrate compared with controls ( P <0.001). Intravital microscopy revealed significantly less leukocyte adhesion in wild-type mice injected with IL-19 and fed an atherogenic diet compared with controls. Treatment of cultured endothelial cells, vascular smooth muscle cells, and bone marrow–derived macrophages with IL-19 resulted in a significant decrease in chemokine mRNA and mRNA stability protein human antigen R. Conclusions—: These data suggest that IL-19 is a potent inhibitor of experimental atherosclerosis, with diverse mechanisms including immune cell polarization, decrease in macrophage adhesion, and decrease in gene expression. This may identify IL-19 as a novel therapeutic to limit vascular inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fan, X. C., & Steitz, J. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3448 · Cited by 866
Research works printed but not linked: 42
- 10.1056/NEJM199901143400207 · DOI · Paper page
- 10.1038/nature01323 · DOI · Paper page
- 10.1097/01.mol.0000182532.11512.90 · DOI
- 10.2353/ajpath.2008.070776 · DOI · Paper page
- 10.1038/nri1882 · DOI · Paper page
- 10.1124/pr.55.1.5 · DOI · Paper page
- 10.1093/cvr/cvn120 · DOI · Paper page
- 10.1161/01.res.0000018941.10726.fa · DOI · Paper page
- 10.1007/BF03402102 · DOI · Paper page
- 10.1096/fj.01-0483fje · DOI · Paper page
- 10.1161/01.atv.0000134378.86443.cd · DOI · Paper page
- 10.2353/ajpath.2007.060857 · DOI
- 10.1016/S0002-9440(10)63471-2 · DOI · Paper page
- 10.1038/sj.gene.6363714 · DOI · Paper page
- 10.1002/eji.200425523 · DOI · Paper page
- 10.1016/j.intimp.2004.01.005 · DOI
- 10.1016/j.cytogfr.2010.08.005 · DOI
- 10.1517/14728222.11.5.601 · DOI · Paper page
- 10.2353/ajpath.2008.080163 · doi:10.2353/ajpath.2008.080163
- 10.1016/j.yjmcc.2010.04.016 · DOI
- 10.1146/annurev.immunol.22.012703.104622 · DOI · Paper page
- 10.1111/j.1365-2133.2005.06665.x · DOI
- 10.7150/ijms.7.284 · DOI
- 10.1161/atvbaha.110.214916 · DOI
- 10.1073/pnas.0409015102 · DOI · Paper page
- 10.1161/01.ATV.20.5.1177 · DOI · Paper page
- 10.1073/pnas.97.13.6930 · DOI · Paper page
- 10.2353/ajpath.2008.070776 · DOI · Paper page
- 10.1016/S0021-9150(99)00011-8 · DOI · Paper page
- 10.1152/ajpcell.00069.2013 · DOI
- 10.1161/01.atv.0000232502.88144.6f · DOI
- 10.1016/j.athoracsur.2011.04.061 · doi:10.1016/j.athoracsur.2011.04.061
- 10.1016/j.immuni.2005.09.015 · DOI · Paper page
- 10.1084/jem.20071868 · DOI · Paper page
- 10.1016/S0002-9440(10)63471-2 · DOI · Paper page
- 10.1161/circulationaha.109.924886 · DOI · Paper page
- 10.1084/jem.20090545 · DOI · Paper page
- 10.1038/nm1343 · DOI · Paper page
- 10.1371/journal.pone.0000779 · DOI · Paper page
- 10.1161/atvbaha.107.149179 · DOI · Paper page
- 10.4049/jimmunol.151.2.588 · doi:10.4049/jimmunol.151.2.588
- 10.1189/jlb.72.3.503 · DOI
Cited by
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Ramji, D. P., & Davies, T. S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.04.003 · Cited by 469
The IL-20 subfamily of cytokines — from host defence to tissue homeostasis
Rutz, S., Wang, X., & Ouyang, W. (2014) · Nature Reviews Immunology · doi:10.1038/nri3766 · Cited by 416
The arterial microenvironment: the where and why of atherosclerosis
Yurdagul, A., Finney, A. C., Woolard, M. D., & Orr, A. W. (2016) · Biochemical Journal · doi:10.1042/bj20150844 · Cited by 185
Self-citationMazan-Mamczarz, K., Tsitsipatis, D., Childs, B. G., Carr, A. E., Dos Santos, C. R., Anerillas, C., Romero, B., Gregg, J. M., Henry-Smith, C., Okereke, A. N., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00889-z · Cited by 48
DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Herman, A. B., Tsitsipatis, D., Anerillas, C., Mazan-Mamczarz, K., Carr, A. E., Gregg, J. M., Wang, M., Zhang, J., Michel, M., Henry-Smith, C. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165933 · Cited by 50
Metadata
- Authors
- Ellison, S., Gabunia, K., Kelemen, S. E., England, R. N., Scalia, R., Richards, J. M., Orr, A. W., Traylor, J. G., Rogers, T., Cornwell, W., Berglund, L. M., Goncalves, I., Gomez, M. F., & Autieri, M. V.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2013-10
- Volume
- 33
- Issue
- 10
- Pages
- 2316-2324
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2116973505
- Cited by
- 58
- References
- 1
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-01-01)
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.